Trials / Completed
CompletedNCT02332642
Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Universitätsmedizin Mannheim · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This pilot clinical trial aims at evaluating immuno-modulating effects of palliative treatment with specifically dosed standard chemotherapeutics in patients with metastatic melanoma (AJCC stage IV) by assessing myeloid-derived suppressor cells' (MDSCs) count and activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Immuno-monitoring |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-31
- First posted
- 2015-01-07
- Last updated
- 2017-03-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02332642. Inclusion in this directory is not an endorsement.